NCT00293800 arm group 9e950067c51cb778a2bf4a5cda00e56b [clinicaltrials_resource:NCT00293800/arm-group/9e950067c51cb778a2bf4a5cda00e56b]
Latanoprost 0.005% Ophthalmic Solution (XALATAN) [clinicaltrials_resource:235889987879a2155f56306f4dabb0d9]Timolol 0.5% Ophthalmic Solution [clinicaltrials_resource:d94021b58d85afc6e192e73d1bbe7e20]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00293800]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00293800 arm group 9e950067c51cb778a2bf4a5cda00e56b [clinicaltrials_resource:NCT00293800/arm-group/9e950067c51cb778a2bf4a5cda00e56b]
Bio2RDF identifier
NCT00293800/arm-group/9e950067c51cb778a2bf4a5cda00e56b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 950067c51cb778a2bf4a5cda00e56b
description [clinicaltrials_vocabulary:description]
One drop Timolol 0.5% in the s ...... evening at 8 p.m. for 3 months
identifier
clinicaltrials_resource:NCT00293800/arm-group/9e950067c51cb778a2bf4a5cda00e56b
title
NCT00293800 arm group 9e950067c51cb778a2bf4a5cda00e56b
@en
type
label
NCT00293800 arm group 9e950067 ...... 50067c51cb778a2bf4a5cda00e56b]
@en